DermTech Q1 2024 Adj EPS $(0.58) Misses $(0.57) Estimate, Sales $3.85M Miss $3.99M Estimate
Portfolio Pulse from Benzinga Newsdesk
DermTech reported Q1 2024 adjusted EPS of $(0.58), missing estimates by 1.75%, and sales of $3.85M, missing estimates by 3.72%. This represents a 10.58% increase in sales compared to the same period last year.
May 14, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DermTech's Q1 2024 earnings and sales missed estimates, with a slight increase in sales compared to last year.
Missing both EPS and sales estimates typically leads to negative investor sentiment in the short term, potentially causing a decrease in stock price. The slight increase in year-over-year sales may not be sufficient to offset the negative impact of the earnings miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100